Katie Wilson

1.1k total citations
21 papers, 702 citations indexed

About

Katie Wilson is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Katie Wilson has authored 21 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Orthopedics and Sports Medicine, 7 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Katie Wilson's work include Bone health and osteoporosis research (8 papers), Bone health and treatments (7 papers) and Quantum Dots Synthesis And Properties (2 papers). Katie Wilson is often cited by papers focused on Bone health and osteoporosis research (8 papers), Bone health and treatments (7 papers) and Quantum Dots Synthesis And Properties (2 papers). Katie Wilson collaborates with scholars based in United States, United Kingdom and Switzerland. Katie Wilson's co-authors include Raphaël Lévy, Arthur Taylor, David G. Fernig, Patricia Murray, Ralph C. Schimmer, Judith G. Hall, Juan J. Gershanik, Kenneth N. Rosenbaum, H. Chen and Susan D. Reed and has published in prestigious journals such as Chemical Society Reviews, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Katie Wilson

20 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katie Wilson United States 12 209 185 177 140 103 21 702
Thomas C Lee United States 19 295 1.4× 173 0.9× 189 1.1× 209 1.5× 37 0.4× 52 1.1k
Christine Wallace United States 14 334 1.6× 99 0.5× 176 1.0× 243 1.7× 21 0.2× 28 1.0k
Kouji Yamaguchi Japan 19 220 1.1× 172 0.9× 309 1.7× 247 1.8× 16 0.2× 55 978
Daniel P. Collins United States 11 153 0.7× 21 0.1× 45 0.3× 110 0.8× 97 0.9× 21 551
Florian Sevelda Austria 19 170 0.8× 34 0.2× 203 1.1× 336 2.4× 30 0.3× 31 959
Christine Rangger Austria 17 159 0.8× 54 0.3× 293 1.7× 187 1.3× 9 0.1× 46 825
Zeyu Xiao China 17 198 0.9× 36 0.2× 83 0.5× 51 0.4× 13 0.1× 46 826
Yanli Ding China 12 204 1.0× 21 0.1× 184 1.0× 59 0.4× 23 0.2× 38 1.2k
Steen Ingemann Hansen Denmark 20 574 2.7× 27 0.1× 112 0.6× 52 0.4× 29 0.3× 94 1.3k
M. Sivakumaran United Kingdom 17 146 0.7× 22 0.1× 73 0.4× 43 0.3× 138 1.3× 50 694

Countries citing papers authored by Katie Wilson

Since Specialization
Citations

This map shows the geographic impact of Katie Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie Wilson more than expected).

Fields of papers citing papers by Katie Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie Wilson. The network helps show where Katie Wilson may publish in the future.

Co-authorship network of co-authors of Katie Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Katie Wilson. A scholar is included among the top collaborators of Katie Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie Wilson. Katie Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Whelan, Maxine, et al.. (2023). Use of e-cigarettes in pregnancy: A systematic review of evidence published from 2020-2022. Journal of Public Health. 33(2). 315–328. 11 indexed citations
3.
Wilson, Katie, et al.. (2022). Targeted glucocorticoid analysis using ion mobility-mass spectrometry (IM-MS). SHILAP Revista de lepidopterología. 24. 50–56. 14 indexed citations
4.
Seto, Edmund, et al.. (2022). Actigraphy and sleep‐monitoring devices to help differentiate dementia with Lewy bodies from Alzheimer’s disease. Alzheimer s & Dementia. 18(S6). 1 indexed citations
5.
Wilson, Katie & Jon Wakefield. (2022). A probabilistic model for analyzing summary birth history data. Demographic Research. 47. 291–344. 1 indexed citations
6.
Wilson, Katie, et al.. (2021). Native Ubiquitin Structural Changes Resulting from Complexation with β-Methylamino- l -alanine (BMAA). Journal of the American Society for Mass Spectrometry. 32(4). 895–900. 6 indexed citations
7.
Wilson, Katie & Jon Wakefield. (2018). Pointless spatial modeling. Biostatistics. 21(2). e17–e32. 13 indexed citations
8.
Cai, En, Pinghua Ge, Sang Hak Lee, et al.. (2014). Stable Small Quantum Dots for Synaptic Receptor Tracking on Live Neurons. Angewandte Chemie International Edition. 53(46). 12484–12488. 62 indexed citations
9.
Cai, En, Pinghua Ge, Sang Hak Lee, et al.. (2014). Stable Small Quantum Dots for Synaptic Receptor Tracking on Live Neurons. Angewandte Chemie. 126(46). 12692–12696. 9 indexed citations
10.
Taylor, Arthur, Katie Wilson, Patricia Murray, David G. Fernig, & Raphaël Lévy. (2012). Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet?. Chemical Society Reviews. 41(7). 2707–2707. 141 indexed citations
11.
Epstein, Sol, et al.. (2006). Oral ibandronate in the management of postmenopausal osteoporosis: Review of upper gastrointestinal safety. Maturitas. 54(1). 1–10. 18 indexed citations
12.
Reginster, Jean‐Yves, et al.. (2006). Monthly Oral Ibandronate Is Well Tolerated and Efficacious in Postmenopausal Women: Results From the Monthly Oral Pilot Study. Obstetrical & Gynecological Survey. 61(4). 250–251. 3 indexed citations
13.
Felsenberg, Dieter, Paul D. Miller, Gabriele Armbrecht, et al.. (2005). Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis. Bone. 37(5). 651–654. 54 indexed citations
14.
Davé, Nisha, et al.. (2005). Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate. British Journal of Clinical Pharmacology. 59(5). 598–601. 32 indexed citations
15.
Reginster, Jean‐Yves, Katie Wilson, Étienne Dumont, Bernard Bonvoisin, & Joanne Barrett. (2005). Monthly Oral Ibandronate Is Well Tolerated and Efficacious in Postmenopausal Women: Results from the Monthly Oral Pilot Study. The Journal of Clinical Endocrinology & Metabolism. 90(9). 5018–5024. 45 indexed citations
16.
Reginster, Jean‐Yves, et al.. (2003). Oral monthly ibandronate decrease bone turnover in postmenopausal women with low bone mass: results from the monthly oral pilot study (MOPS). Open Repository and Bibliography (University of Liège). 1 indexed citations
17.
Cooper, Cyrus, Ronald Emkey, Robert H. McDonald, et al.. (2003). Efficacy and Safety of Oral Weekly Ibandronate in the Treatment of Postmenopausal Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 88(10). 4609–4615. 58 indexed citations
18.
Ilson, David H., Manjit S. Bains, David P. Kelsen, et al.. (2003). Phase I Trial of Escalating-Dose Irinotecan Given Weekly With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Cancer. Journal of Clinical Oncology. 21(15). 2926–2932. 79 indexed citations
19.
Cooper, Cyrus, Gillian Hawker, Ronald Emkey, et al.. (2002). Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis (PMO). Journal of Bone and Mineral Research. 17. 2 indexed citations
20.
Hall, Judith G., Susan D. Reed, Kenneth N. Rosenbaum, et al.. (1982). Limb pterygium syndromes: A review and report of eleven patients. American Journal of Medical Genetics. 12(4). 377–409. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas C Lee Breakdown of academic impact, for papers by Christine Wallace Breakdown of academic impact, for papers by Kouji Yamaguchi Breakdown of academic impact, for papers by Daniel P. Collins Breakdown of academic impact, for papers by Florian Sevelda Breakdown of academic impact, for papers by Christine Rangger Breakdown of academic impact, for papers by Zeyu Xiao Breakdown of academic impact, for papers by Yanli Ding Breakdown of academic impact, for papers by Steen Ingemann Hansen Breakdown of academic impact, for papers by M. Sivakumaran
Rankless by CCL
2026